Lestat Ali

Education and training

Harvard

Research

Publications

29 attributed works. Counts reflect resolved authorship and may be incomplete.

• 2025

  Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

  Journal for ImmunoTherapy of Cancer
• 2024

  Data from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
• 2024

  Arm A count matrices 3 from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
• 2024

  TCR raw data 2 from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
• 2024

  Table S1 from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
• 2024

  Arm B count matrices 4 from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
• 2024

  Supplementary Data 1 from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
• 2024

  PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

  Clinical Cancer Research
• 2023

  PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer

  Journal of Experimental Medicine
• 2023

  Supplemental Methods from Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8⁺ T Cell–Effector Responses
• 2023

  Data from Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8⁺ T Cell–Effector Responses
• 2023

  Data from Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation
• 2023

  Supplementary Data from Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation
• 2023

  cIAP1/2 Antagonism Induces Antigen-Specific T Cell–Dependent Immunity

  The Journal of Immunology
• 2023

  Table S2 from Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation
• 2023

  Supplemental Data from Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8⁺ T Cell–Effector Responses
• 2021

  Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis.

  AllergyRCR 1.1614 citesPMID 34614218
• 2021

  Replicability of neural responses to speech accent is driven by study design and analytical parameters

  Scientific Reports
• 2021

  cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes

  Science Translational Medicine
• 2021

  Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation

  Cancer Discovery

Sources

Roster sources establish the listed training role. Additional education, career, and research sources are added as the profile is enriched.

• Internal Medicine Residency roster

Program context: Internal Medicine Residency